Single-cell Analysis Market Is Projected To Grow Robustly By 2030

Single-cell Analysis Market Summary

The global single-cell analysis market size was estimated at USD 4.34 billion in 2023 and is projected to reach USD 13.69 billion by 2030, growing at a CAGR of 18.7% from 2024 to 2030. The market expansion is driven by the growing application of single-cell analysis in disease diagnosis, drug discovery and development, and the increasing adoption of advanced sequencing technologies. Continuous technological innovations in single-cell isolation, analysis, and bioinformatics, coupled with the rising prevalence of cancer and other chronic diseases, are further propelling market growth globally.

Rapid advancements in single-cell technologies now enable comprehensive transcriptome and genome analysis at the level of an individual cell. These studies have demonstrated that different cell types possess distinct functions and lineages, resulting in varied responses to physiological changes in the host environment. Single-cell analysis allows researchers to assess cellular heterogeneity and investigate biological pathways and molecular processes with unprecedented precision. Applications of this technology are expanding rapidly across oncology, immunology, and other biomedical fields. Currently, there are 22 phase-II clinical trials listed on Clinicaltrials.gov utilizing single-cell sequencing technology, highlighting its growing importance in translational research and clinical applications.

Key Market Trends & Insights

• North America dominated the single-cell analysis market in 2023, accounting for a leading revenue share of 40.3%, due to strong research infrastructure, high adoption of advanced technologies, and significant investments in life sciences research.
• Japan held the largest revenue share in the Asia Pacific region, driven by growing biomedical research initiatives, advanced healthcare systems, and increasing clinical adoption of single-cell technologies.
• Based on product type, the consumables segment dominated the market with a revenue share of 54.8% in 2023, reflecting the recurring need for reagents, kits, and other consumable materials for single-cell experiments.
• In terms of application, the cancer segment led the market with a revenue share of 32.1% in 2023, highlighting the critical role of single-cell analysis in understanding tumor heterogeneity and developing targeted therapies.
• Based on workflow, the data analysis segment accounted for the largest market share of 38.5% in 2023, emphasizing the importance of computational tools and bioinformatics in interpreting complex single-cell datasets.

Order a free sample PDF of the Single-cell Analysis Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 4.34 Billion
• 2030 Projected Market Size: USD 13.69 Billion
• CAGR (2024-2030): 18.7%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Key players operating in the market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling the market growth.

Key Players

• Thermo Fisher Scientific, Inc
• QIAGEN NV
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Merck KGaA
• Becton, Dickinson & Company (BD)
• Fluidigm Corporation (Standard BioTools Inc.)
• 10x Genomics, Inc.
• BGI
• Novogene Co, Ltd.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global single-cell analysis market is poised for significant growth, driven by technological innovations, rising adoption in cancer research, and expanding applications in drug discovery and precision medicine. North America leads in market share, while Asia Pacific, particularly Japan, is rapidly adopting single-cell technologies for clinical and research purposes. Consumables, cancer applications, and data analysis workflows dominate the market due to their critical role in research and diagnostics. Over the forecast period, continuous advancements in sequencing technologies, increasing clinical trials, and the growing need for personalized medicine will ensure sustained market expansion and create new opportunities for stakeholders worldwide.